These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14529149)

  • 1. Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
    Suzuki H; Masaoka T; Nomura S; Hoshino Y; Kurabayashi K; Minegishi Y; Suzuki M; Ishii H
    Keio J Med; 2003 Sep; 52(3):163-73. PubMed ID: 14529149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
    Kato A; Kato H; Hirashima N; Sakamoto T; Nukaya H; Ito K; Matsunaga S; Kondo H; Tanaka Y; Sakakibara K
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1209-16. PubMed ID: 15570869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
    J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
    Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
    J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
    Miki I; Aoyama N; Sakai T; Shirasaka D; Wambura CM; Maekawa S; Kuroda K; Tamura T; Kita T; Sakaeda T; Okumura K; Kasuga M
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):27-33. PubMed ID: 12544691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amount of Helicobacter pylori in gastric mucus during anti-H. pylori treatment.
    Furuta T; Takashima M; Futami H; Arai H; Hanai H; Kaneko E
    J Gastroenterol Hepatol; 1998 May; 13(5):511-5. PubMed ID: 9641650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.
    Perng CL; Kim JG; El-Zimaity HM; Osato MS; Graham DY
    Dig Dis Sci; 1998 Mar; 43(3):464-7. PubMed ID: 9539638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
    Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T
    J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Bozzola L; Fortunato A; Rassu M; Meli S; Soffiati G; Scagnelli M; Di Mario F; Valerio G
    J Gastroenterol Hepatol; 1999 May; 14(5):468-75. PubMed ID: 10355512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of various diagnostic tests to evaluate cure of Helicobacter pylori infection.
    Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
    J Gastroenterol; 1996 Apr; 31(2):171-4. PubMed ID: 8680535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
    Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
    J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
    Suzuki H; Masaoka T; Sakai G; Ishii H; Hibi T
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1652-60. PubMed ID: 16246181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.